Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
Leila Motedayеn Aval, James E. Pease, Rohini Sharma, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3323-3323
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Alexiane Decout, Jason D. Katz, Shankar Venkatraman, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 9, pp. 548-569
Open Access | Times Cited: 1300
Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1033
The STING1 network regulates autophagy and cell death
Ruoxi Zhang, Rui Kang, Daolin Tang
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 163
STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)
Yasmine Messaoud‐Nacer, Elodie Culerier, Stéphanie Rose, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 140
Tumor-targeted delivery of a STING agonist improves cancer immunotherapy
Youtong Wu, Yan Fang, Wei Qi, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 49
Open Access | Times Cited: 108
The cGAS/STING Pathway: A Novel Target for Cancer Therapy
Yu Gan, M Kellis, Shuangze Han, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 106
Activation of STING by targeting a pocket in the transmembrane domain
Defen Lu, Guijun Shang, Jie Li, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 557-562
Open Access | Times Cited: 103
The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 82
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 46
Mn-based cGAS-STING activation for tumor therapy
Aiping Huang, Wenhu Zhou
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 1, pp. 19-43
Open Access | Times Cited: 44
Bioactivable STING Nanoagonists to Synergize NIR‐II Mild Photothermal Therapy Primed Robust and Long‐Term Anticancer Immunity
Wen Ma, Rui Sun, Longguang Tang, et al.
Advanced Materials (2023) Vol. 35, Iss. 48
Closed Access | Times Cited: 40
Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation
Suyog Shaha, Danika Rodrigues, Samir Mitragotri
Journal of Controlled Release (2024) Vol. 367, pp. 737-767
Closed Access | Times Cited: 18
cGAS–STING, an important signaling pathway in diseases and their therapy
Qijie Li, Ping Wu, Qiujing Du, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 18
Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
Yuxuan Peng, Shuang Liang, Qian‐Fang Meng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 17
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Radiotherapy and immunology
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 15
STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems
Hitesh Vasiyani, Bhumika Wadhwa
Cellular Signalling (2025), pp. 111647-111647
Closed Access | Times Cited: 1
Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
Xinyun Qiu, Yan Qu, Beibei Guo, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 498-510
Closed Access | Times Cited: 71
Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
Kathleen M. McAndrews, Sara P.Y., Valerie S. LeBleu, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100523-100523
Open Access | Times Cited: 60
A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy
Taokun Luo, Geoffrey T. Nash, Xiaomin Jiang, et al.
Advanced Materials (2022) Vol. 34, Iss. 39
Open Access | Times Cited: 47
Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy
Wen Song, Shujun Song, Jing Kuang, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 15977-15993
Closed Access | Times Cited: 46
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
André E. Nel, Kuo‐Ching Mei, Yu‐Pei Liao, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 5184-5232
Open Access | Times Cited: 43
Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy
Aatman S. Doshi, Susan Cantin, Laura B. Prickett, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 721-733
Closed Access | Times Cited: 41
The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review
Monika Gudowska-Sawczuk, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5283-5283
Open Access | Times Cited: 38
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
Jieun Han, Jaesung Lim, Chi‐Pin James Wang, et al.
Nano Convergence (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top